Equities research analysts expect athenahealth, Inc (NASDAQ:ATHN) to report earnings per share (EPS) of $0.74 for the current fiscal quarter, according to Zacks Investment Research. Twenty Two analysts have provided estimates for athenahealth’s earnings, with estimates ranging from $0.38 to $0.90. athenahealth reported earnings per share of $0.32 during the same quarter last year, which indicates a positive year over year growth rate of 131.3%. The company is expected to issue its next earnings report after the market closes on Thursday, April 26th.
On average, analysts expect that athenahealth will report full year earnings of $3.79 per share for the current fiscal year, with EPS estimates ranging from $3.10 to $4.15. For the next financial year, analysts forecast that the firm will report earnings of $4.49 per share, with EPS estimates ranging from $3.72 to $5.42. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for athenahealth.
athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.48. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The firm had revenue of $329.20 million for the quarter, compared to analysts’ expectations of $319.64 million. During the same period in the previous year, the firm earned $0.62 earnings per share. The business’s revenue was up 14.2% compared to the same quarter last year.
ATHN has been the topic of several research analyst reports. BidaskClub cut athenahealth from a “hold” rating to a “sell” rating in a research note on Tuesday, January 16th. ValuEngine cut athenahealth from a “hold” rating to a “sell” rating in a research note on Friday, February 2nd. KeyCorp reissued a “buy” rating and set a $152.00 target price on shares of athenahealth in a research note on Friday, January 12th. Citigroup initiated coverage on athenahealth in a research note on Thursday, January 4th. They set a “neutral” rating on the stock. Finally, SunTrust Banks boosted their target price on athenahealth to $180.00 and gave the company a “buy” rating in a research note on Monday, February 5th. Three investment analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and seven have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $144.35.
In other athenahealth news, SVP Bradford Kyle Armbrester sold 2,235 shares of the business’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $138.70, for a total value of $309,994.50. Following the sale, the senior vice president now directly owns 10,146 shares of the company’s stock, valued at $1,407,250.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jonathan Bush sold 5,000 shares of the business’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $122.69, for a total value of $613,450.00. Following the completion of the sale, the chief executive officer now directly owns 320,807 shares in the company, valued at $39,359,810.83. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 47,555 shares of company stock worth $6,682,463. 3.20% of the stock is owned by insiders.
A number of institutional investors have recently added to or reduced their stakes in ATHN. Allianz Asset Management GmbH boosted its holdings in athenahealth by 67.0% in the fourth quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock worth $73,939,000 after acquiring an additional 223,006 shares in the last quarter. ARK Investment Management LLC boosted its holdings in athenahealth by 55.5% in the fourth quarter. ARK Investment Management LLC now owns 379,439 shares of the health services provider’s stock worth $50,481,000 after acquiring an additional 135,383 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD boosted its holdings in athenahealth by 40.3% in the fourth quarter. Sumitomo Mitsui Asset Management Company LTD now owns 454,160 shares of the health services provider’s stock worth $60,421,000 after acquiring an additional 130,545 shares in the last quarter. ArrowMark Colorado Holdings LLC boosted its holdings in athenahealth by 30.1% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock worth $68,098,000 after acquiring an additional 118,411 shares in the last quarter. Finally, Ascend Capital LLC bought a new stake in athenahealth in the fourth quarter worth $11,382,000.
ATHN opened at $142.20 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84. athenahealth has a 52-week low of $95.01 and a 52-week high of $158.66. The company has a market cap of $5,789.32, a PE ratio of 90.57, a price-to-earnings-growth ratio of 3.02 and a beta of 1.13.
WARNING: This story was published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.thelincolnianonline.com/2018/04/21/analysts-expect-athenahealth-inc-athn-to-announce-0-74-earnings-per-share.html.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.